Search the Newsreel

Broadcom and Samsung’s Expanded Pact Could Unleash $1 Trillion Revenue Wave

Broadcom will receive the bulk of its memory needs from Samsung through 2030, according to J.P. Morgan. Continue Reading

Gossamer Bio shares jump after FDA update and seralutinib rights return

Gossamer Bio (NASDAQ:GOSS) shares surged 25% following a positive FDA regulatory update for its lead drug candidate, seralutinib, and the regaining of full global rights to the therapy. The company anticipates submitting a New Drug Application (NDA) for seralutinib in pulmonary arterial hypertension (PAH) …

Samsara EVP, CTO John Bicket sells $9.5m in stock in July

Samsara Inc.'s EVP, CTO, and Director John Bicket sold 262,900 shares of Class A Common Stock for approximately $9.5 million on July 21 and 22, 2026, under Rule 10b5-1 trading plans. These sales occurred during a challenging week for the stock, which declined nearly …

Gossamer Bio stock surges 25% on FDA regulatory update

Gossamer Bio Inc. (NASDAQ:GOSS) shares surged 25% after the company announced a regulatory update from the FDA regarding its drug seralutinib for pulmonary arterial hypertension (PAH) and reacquired worldwide rights to the drug. The company plans to submit a New Drug Application (NDA) for …

Broadcom’s Expanded Samsung Pact Shows AI Trade Is Still All About Memory

Broadcom will receive the bulk of its memory needs from Samsung through 2030, according to J.P. Morgan. Continue Reading

Why is Bernstein bullish on memory stocks after Samsung, Nvidia deals?

Investing.com -- Bernstein has reiterated its bullish stance on memory chipmakers following a wave of multibillion-dollar partnerships announced at an AI Summit hosted by the South Korean government in San Francisco on Friday, where Samsung, SK Hynix, Nvidia and Broadcom unveiled new agreements spanning …

Samfine Creation Holdings Group Ltd

This article provides a revenue breakdown for Samfine Creation Holdings Group Ltd (SFHG), detailing its business segments and regional revenue contributions. For FY2024, the company generated revenue from book products and novelty and packaging products, with all revenue originating from the PRC. It also …

[Click e-Stock] "Samsung Epis Holdings: Focus on New Drug Development Strategy Over Short-Term Earnings... Target Price Lowered"

Sambhaav Media Share Price Forecast to 2030

Gossamer Bio shares surge after FDA filing update; cash concerns and dilution still loom

Sampann Utpadan India Share Price Forecast to 2030

Boston Beer Faces Weak Demand While Margins and Innovation Diverge

Samvardhana Motherson International shares gain 2.06 percent

Motherson Sumi Wiring Q1 Results: Earnings call set for Aug 4

Versamet Royalties Ord Shs (VMET) Financial Health: Profitability & Balance Sheet Analysis

Samfine Creation Holdings Group Ltd (SFHG) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Samfine Creation Holdings Group Ltd (SFHG), including its current stock price, market cap, and a note on undisclosed P/E data. It appears to be an overview page from TradingKey, indicating where valuation metrics and related analyses would …

Samfine Creation Holdings Group Ltd (SFHG) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Samfine Creation Holdings Group Ltd (SFHG), detailing various indicators and moving averages. It offers "Buy," "Sell," and "Neutral" signals based on tools like MACD, RSI, KDJ, and moving averages (MA5 to MA200). The analysis concludes with a …

Samfine Creation Holdings Group Ltd (SFHG) Institutional Confidence

This article provides details on the institutional confidence in Samfine Creation Holdings Group Ltd (SFHG), focusing on changes in shareholdings by various investment firms. Key shareholders such as Cheng (Wayne), Citadel Advisors LLC, XTX Markets LLC, and Two Sigma Investments, LP are listed with …

Samfine Creation Holdings Group Ltd (SFHG) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Samfine Creation Holdings Group Ltd (SFHG), including future EPS and revenue growth estimates. It is derived from TradingKey, which offers general information on investment products. The data is updated as of July 26, 2026.

Sampo plc’s share buybacks week 30/2026

Sampo plc Sampo plc, stock exchange release, 27 July 2026 at 8:30 am EEST Sampo plc's share buybacks week 30/2026 During week 30 (20 July 2026 - 24 July 2026), Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN …

Kospi index and U.S. stock futures jump as new Hormuz talks send oil prices plunging amid Iran war pause while Wall Street awaits Fed meeting

Investors were bullish on Sunday evening as the U.S. and Iran continued to halt their attacks on each other, providing space for negotiations that could reopen the Strait of Hormuz. Meanwhile, Wall Street is also looking ahead to a busy week of tech earnings …

Samfine Creation Holdings Group Ltd (SFHG) Income Statement

This article provides the income statement for Samfine Creation Holdings Group Ltd (SFHG), detailing financial performance. It includes key financial figures like revenue, net income, and operating profit for fiscal year 2025, and offers FAQs on how to interpret income statements and crucial metrics …

Samfine Creation Holdings Group Limited Revenue Breakdown – NASDAQ:SFHG

Boston Beer Company, Inc. Class A Revenue Breakdown – MUN:BBEA

This article provides a revenue breakdown for Boston Beer Company, Inc. Class A (MUN:BBEA), highlighting that the Alcohol Beverages segment generated 1.67 billion EUR last year, down from 1.94 billion EUR the previous year. The United States was the largest contributor to revenue, accounting …

Gossamer Bio, Inc. Revenue Breakdown – SWB:4GB

This article from TradingView provides a high-level overview of Gossamer Bio, Inc.'s financial information on the Stuttgart Stock Exchange (SWB:4GB). It indicates that the primary financial segment information for revenue breakdown, including source and country, is not publicly available on this specific page. The …

Samsara, Inc. Class A (IOT) Q2 2025 Earnings Report - Results, Call & Slides

Samsara, Inc. Class A (IOT) reported its Q2 2025 earnings, significantly beating analyst expectations with an actual EPS of $0.88 against a consensus of $0.16, and revenue of $5.26 billion compared to an expected $5.07 billion. The company achieved a year-over-year revenue growth of …

Apple (AAPL) Readies Foldable iPhone As Samsung Launches New Rival Phones

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Samsung has launched new foldable phones as Apple, NasdaqGS:AAPL, is reported to be preparing its first foldable iPhone for a planned September debut. This move …

Samsung (KOSE:A005930) Launches Galaxy Watch Ultra2 And Watch9 With AI Health Features

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Samsung Electronics launched the Galaxy Watch Ultra2 and Galaxy Watch9, expanding its smartwatch lineup with new models focused on AI-powered health and fitness …

Citi brush off memory "peak-out" fears, reiterates Buy on Samsung and SK Hynix

Investing.com - South Korean memory chipmakers are facing unjustified stock pullbacks over unfounded fears of a cyclical downturn, as supply chains remain severely tight and artificial intelligence infrastructure drives unprecedented demand, according to a report by Citi Research. The Wall Street bank reiterated its …

Samsara Inc. (IOT) grants 7,801 RSUs to board director Alyssa Henry

Samsara Inc. board director Alyssa Henry received a grant of 7,801 restricted stock units (RSUs) on July 22, 2026. These RSUs will vest in full on the earlier of July 22, 2027, or the day prior to the next annual stockholders meeting, provided she …

GOSS|Gossamer Bio Inc|Price:0.136|Chg%:-0.006

Gossamer Bio Inc. (GOSS) is a late-stage biopharmaceutical company focusing on seralutinib for pulmonary arterial hypertension. The company exhibits stable fundamentals and high growth potential but is currently considered fairly valued within its industry. Despite weak recent stock market performance, its stock price is …

Samsara, Inc. Class A Revenue Breakdown – TRADEGATE:YL8

Samsara, Inc. Class A (TRADEGATE:YL8) generated a total revenue of 1.37 billion EUR last year. The majority of this revenue, 1.34 billion EUR, came from its Subscription segment, showing a growth from 1.18 billion EUR in the previous year. The United States was the …

Samsung and SK Hynix unveil $950 billion US chip supply partnerships

Investing.com -- Samsung Electronics and SK Hynix will pursue memory-chip supply partnerships with major U.S. technology companies valued at a combined $950 billion, Reuters reported, citing South Korean presidential adviser Kim Yong-beom. SK Hynix is expected to supply $750 billion of memory chips to …

Boston Beer Company (SAM) Reported Weaker Q2 Results, Is The Stock Still Below Fair Value?

ITC Hotels, Chalet, Ventive, IHCL, SAMHI: Hotel stocks to buy despite travel disruptions

Form 13D/A Gossamer Bio For: 24 July By Investing.com

This article announces the filing of a Form 13D/A for Gossamer Bio on July 24. The filing is a standard regulatory disclosure related to significant ownership stakes in a company. The article itself is very brief, mainly serving as an announcement for this regulatory …